Effects of glycerol processing on the biomechanical, structural, optical, and antimicrobial properties of human amniotic membrane.
5 affiliations
- 1Department of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. [email protected].
- 2Department of Surgery, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- 3Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
- 4Department of Obstetrics and Gynaecology, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
- 5Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.
Abstract
Human amniotic membrane (hAM) is used as a biological dressing in burn care, and preservation methods may influence its structural and functional characteristics. This study evaluated the effects of a glycerol-based processing and preservation method on properties of hAM. Placentas were obtained from 142 consenting donors following elective caesarean section at a tertiary academic hospital. hAM was processed using ≥99.5% glycerol with agitation cycles and intermediate saline rinses following antibiotic-antifungal decontamination. Paired processed and unprocessed samples from 71 donors were assessed for biomechanical properties, optical transmittance, thickness, bacterial inhibition, and histological characteristics. Statistical analyses included paired t-tests, repeated-measures ANOVA, and effect sizes (Cohen's d). Processing resulted in modest reductions in ultimate tensile strength (- 7.6%) and tensile stress (- 6.1%), with small effect sizes, while tensile strain was not significantly altered. Optical transmittance increased from 90.8 to 97.1% (p < 0.001; Cohen's d -0.92), while thickness decreased by 2.9%. Following 12 months of refrigerated storage, glycerol-processed hAM produced larger inhibition zones than unprocessed hAM against all five tested bacterial species under the same conditions. Qualitative histological assessment demonstrated epithelial loss, reduced stromal cellularity, and altered stromal morphology, while the basement membrane remained visibly continuous. Processed hAM demonstrated measurable biomechanical properties and bacterial inhibition, together with increased optical transmittance, and processing-associated histological changes. These in vitro findings characterize the effects of the glycerol-based processing and preservation method but do not establish clinical efficacy. Further in vivo evaluation is required to determine whether these laboratory findings translate into safe and effective clinical performance.
Related
- Corvis ST Assessment of Corneal Biomechanical Properties in Patients with Type 2 Diabetes Mellitus
- Clinical assessment of ex vivo biomechanical properties of the human cataractous lens using machine learning
- A study on the changes in the microstructure of trabecular bone and the biomechanical properties in patients with osteoporotic fractures and the correlation between them
- Spatiotemporal evolution of corneal biomechanical properties after cross-linking based on optical coherence elastography.
- From structural repair to biomechanical compatibility: Aortic stiffness after open and endovascular aortic repair.
BibTeX
@article{ndhlovu2026effects,
title = {{Effects of glycerol processing on the biomechanical, structural, optical, and antimicrobial properties of human amniotic membrane.}},
author = {Cleopatra Ndhlovu and Adelin Muganza and Lawrence Chauke and Deirdre Kruger},
journal = {Cell and tissue banking},
year = {2026},
month = oct,
doi = {10.1007/s10561-026-10261-z},
url = {https://europepmc.org/article/MED/42961686},
note = {CC BY},
}
RIS
TY - JOUR
TI - Effects of glycerol processing on the biomechanical, structural, optical, and antimicrobial properties of human amniotic membrane.
AU - Cleopatra Ndhlovu
AU - Adelin Muganza
AU - Lawrence Chauke
AU - Deirdre Kruger
PY - 2026
DA - 2026/10/30
JO - Cell and tissue banking
DO - 10.1007/s10561-026-10261-z
UR - https://europepmc.org/article/MED/42961686
AB - Human amniotic membrane (hAM) is used as a biological dressing in burn care, and preservation methods may influence its structural and functional characteristics. This study evaluated the effects of a glycerol-based processing and preservation method on properties of hAM. Placentas were obtained from 142 consenting donors following elective caesarean section at a tertiary academic hospital. hAM was processed using ≥99.5% glycerol with agitation cycles and intermediate saline rinses following antibiotic-antifungal decontamination. Paired processed and unprocessed samples from 71 donors were assessed for biomechanical properties, optical transmittance, thickness, bacterial inhibition, and histological characteristics. Statistical analyses included paired t-tests, repeated-measures ANOVA, and effect sizes (Cohen's d). Processing resulted in modest reductions in ultimate tensile strength (- 7.6%) and tensile stress (- 6.1%), with small effect sizes, while tensile strain was not significantly altered. Optical transmittance increased from 90.8 to 97.1% (p < 0.001; Cohen's d -0.92), while thickness decreased by 2.9%. Following 12 months of refrigerated storage, glycerol-processed hAM produced larger inhibition zones than unprocessed hAM against all five tested bacterial species under the same conditions. Qualitative histological assessment demonstrated epithelial loss, reduced stromal cellularity, and altered stromal morphology, while the basement membrane remained visibly continuous. Processed hAM demonstrated measurable biomechanical properties and bacterial inhibition, together with increased optical transmittance, and processing-associated histological changes. These in vitro findings characterize the effects of the glycerol-based processing and preservation method but do not establish clinical efficacy. Further in vivo evaluation is required to determine whether these laboratory findings translate into safe and effective clinical performance.
SN - 1389-9333
SN - 1573-6814
ER -